VENBIO GLOBAL STRATEGIC GP III, LTD's Net Worth
$325 Million
Who is VENBIO GLOBAL STRATEGIC GP III, LTD?
VENBIO GLOBAL STRATEGIC GP III, LTD has an estimated net worth of $325 Million. This is based on reported shares across multiple companies, which include RayzeBio, Inc., Ventyx Biosciences, Inc., and Elevation Oncology, Inc..
SEC CIK
VENBIO GLOBAL STRATEGIC GP III, LTD's CIK is 0001869300
Past Insider Trading and Trends
2023 was VENBIO GLOBAL STRATEGIC GP III, LTD's most active year for acquiring shares with 3 total transactions. VENBIO GLOBAL STRATEGIC GP III, LTD's most active month to acquire stocks was the month of August. 2023 was VENBIO GLOBAL STRATEGIC GP III, LTD's most active year for disposing of shares, totalling 3 transactions. VENBIO GLOBAL STRATEGIC GP III, LTD's most active month to dispose stocks was the month of August. 2021 saw VENBIO GLOBAL STRATEGIC GP III, LTD paying a total of $5,000,000.00 for 3,997,269 shares, this is the most they've acquired in one year. In 2023 VENBIO GLOBAL STRATEGIC GP III, LTD cashed out on 5,126,946 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
RayzeBio, Inc. (RYZB) Snapshot price: $62.12
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 5.16M |
—
|
—
| 5.16M |
Sep 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Ventyx Biosciences, Inc. (VTYX) Snapshot price: $2.34
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
∞
| 4M |
$16.00 |
—
| 4M |
Oct 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Elevation Oncology, Inc. (ELEV) Snapshot price: $3.1182
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||